1. Gluten sensitivity and epilepsy: a systematic review

   • Thomas Julian
   • Marios Hadjivassiliou
   • Panagiotis Zis

   Review Open access 23 August 2018 Pages: 1557 - 1565

   

2. Ocular amyloid imaging at the crossroad of Alzheimer’s disease and age-related macular degeneration: implications for diagnosis and therapy

   • Sally S. Ong
   • Alan D. Proia
   • Eleonora M. Lad

   Review 28 August 2018 Pages: 1566 - 1577

   

3. Cerebellar functional abnormalities in early stage drug-naïve and medicated Parkinson’s disease

   • Shuai Xu
   • Xin-Wei He
   • Xiaoxia Du

   Original Communication 28 March 2019 Pages: 1578 - 1587

   

4. Thrombocytopenia and declines in platelet counts: predictors of mortality and outcome after mechanical thrombectomy

   • Sebastian Mönch
   • Tobias Boeckh-Behrens
   • Benjamin Friedrich

   Original Communication 27 March 2019 Pages: 1588 - 1595

   

5. Rituximab as induction therapy in refractory myasthenia gravis: 18 month follow-up study

   • Nishita Singh
   • Vinay Goyal

   Original Communication 27 March 2019 Pages: 1596 - 1600

6. Olfactory anosognosia is a predictor of cognitive decline and dementia conversion in Parkinson’s disease

   • Han Soo Yoo
   • Seok Jong Chung
   • Phil Hyu Lee

   Original Communication 22 April 2019 Pages: 1601 - 1610

   

7. 15-White Dots APP-Coo-Test: a reliable touch-screen application for assessing upper limb movement impairment in patients with cerebellar ataxias

   • Giuseppe Arcuria
   • Christian Marcotulli
   • Carlo Casali

   Original Communication 06 April 2019 Pages: 1611 - 1622

   

8. Strength and muscle structure preserved during long-term therapy in a patient with hypokalemic periodic paralysis (Cav1.1-R1239G)

   • Marc-André Weber
   • Karin Jurkat-Rott
   • Frank Lehmann-Horn

   Original Communication 01 April 2019 Pages: 1623 - 1632

   

9. Parkinsonian traits in amyotrophic lateral sclerosis (ALS): a prospective population-based study

   • Andrea Calvo
   • Adriano Chiò
   • Mario G. Rizzone

   Original Communication 04 April 2019 Pages: 1633 - 1642

   

10. Serum and CSF neurofilament light chain levels in antibody-mediated encephalitis

    • Sara Mariotto
    • Alberto Gajofatto
    • Sergio Ferrari

    Original Communication 03 April 2019 Pages: 1643 - 1648

    

11. A novel COL6A2 mutation causing late-onset limb-girdle muscular dystrophy

    • Manu Jokela
    • Sara Lehtinen
    • Bjarne Udd

    Original Communication Open access 08 April 2019 Pages: 1649 - 1654

    

12. Antecedent infections in Fisher syndrome: sources of variation in clinical characteristics

    • Michiaki Koga
    • Masahiko Kishi
    • Takashi Kanda

    Original Communication Open access 06 April 2019 Pages: 1655 - 1662

    

13. In search of distinct MS-related fatigue subtypes: results from a multi-cohort analysis in 1.403 MS patients

    • Gesa E. A. Pust
    • Jana Pöttgen
    • Iris-Katharina Penner

    Original Communication 19 April 2019 Pages: 1663 - 1673

    

14. Diagnosis strategy and Yacovino maneuver for anterior canal-benign paroxysmal positional vertigo

    • Xu Yang
    • Xia Ling
    • Ji-Soo Kim

    Original Communication 08 April 2019 Pages: 1674 - 1684

    

15. Amyloid PETs are commonly negative in suspected Alzheimer’s disease with an increase in CSF phosphorylated-tau protein concentration but an Aβ42 concentration in the very high range: a prospective study

    • Chloé Manca
    • Thérèse Rivasseau Jonveaux
    • Antoine Verger

    Original Communication 08 April 2019 Pages: 1685 - 1692

    

16. High-intensity training in patients with spinal and bulbar muscular atrophy

    • Karen Heje
    • Grete Andersen
    • John Vissing

    Original Communication 19 April 2019 Pages: 1693 - 1697

    

17. Financial capacity in frontotemporal dementia and related presentations

    • Sascha Gill
    • Mervin Blair
    • Elizabeth Finger

    Original Communication Open access 22 April 2019 Pages: 1698 - 1707

    

18. Occurrence of cerebral small vessel disease at diagnosis of MPO-ANCA-associated vasculitis

    • Hiroki Tani
    • Koji Nagai
    • Shigeki Arawaka

    Original Communication 13 April 2019 Pages: 1708 - 1715

    

19. Structural correlates of attention dysfunction in Lewy body dementia and Alzheimer’s disease: an ex-Gaussian analysis

    • Julia Schumacher
    • Ruth Cromarty
    • John-Paul Taylor

    Original Communication Open access 21 April 2019 Pages: 1716 - 1726

    

20. Motor, cognitive and behavioral differences in MDS PSP phenotypes

    • Marina Picillo
    • Sofia Cuoco
    • The PSP Salerno study group

    Original Communication 15 April 2019 Pages: 1727 - 1735

    

21. Exploring hyperhidrosis and related thermoregulatory symptoms as a possible clinical identifier for the dysautonomic subtype of Parkinson’s disease

    • Daniel J. van Wamelen
    • Valentina Leta
    • Kallol Ray Chaudhuri

    Original Communication Open access 17 April 2019 Pages: 1736 - 1742

    

22. Pathologic and MRI analysis in acute atypical inflammatory demyelinating lesions

    • Xavier Ayrignac
    • Valérie Rigau
    • Stéphane Kremer

    Original Communication 23 April 2019 Pages: 1743 - 1755

    

23. Parkinson’s-adapted cognitive stimulation therapy: feasibility and acceptability in Lewy body spectrum disorders

    • Sheree A. McCormick
    • Sabina Vatter
    • Iracema Leroi

    Original Communication Open access 04 June 2019 Pages: 1756 - 1770

    

24. Classification of degenerative parkinsonism subtypes by support-vector-machine analysis and striatal ¹²³I-FP-CIT indices

    • Nicolas Nicastro
    • Jennifer Wegrzyk
    • Pierre R. Burkhard

    Original Communication Open access 29 April 2019 Pages: 1771 - 1781

    

25. Primary involvement of neurovascular coupling in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy

    • Andrea Jokumsen-Cabral
    • Ana Aires
    • Pedro Castro

    Original Communication 26 April 2019 Pages: 1782 - 1788

    

26. Seizures and epilepsy in multiple sclerosis: epidemiology and prognosis in a large tertiary referral center

    • Lisa Langenbruch
    • Julia Krämer
    • Stjepana Kovac

    Original Communication 08 May 2019 Pages: 1789 - 1795

    

27. SNCA but not DNM3 and GAK modifies age at onset of LRRK2-related Parkinson’s disease in Chinese population

    • Zhi-hua Yang
    • Yu-sheng Li
    • Yu-ming Xu

    Original Communication 30 April 2019 Pages: 1796 - 1800

28. Livedo racemosa generalisata: an anthological vision through Vladímir Lébedev painting

    • José Berciano

    Letter to the Editors 04 April 2019 Pages: 1801 - 1802

    

29. Obituary for Prof. Dr. Dr. h.c. Dipl. Ing. Frank Lehmann-Horn

    • Holger Lerche
    • Karin Jurkat-Rott
    • Marc-André Weber

    Letter to the Editors 05 April 2019 Pages: 1803 - 1803

30. Anti-natalizumab antibodies during 8 years of natalizumab treatment: effect on natalizumab concentration and α4-integrin receptor saturation

    • Zoé L. E. van Kempen
    • Johannis A. van Rossum
    • Joep Killestein

    Letter to the Editors 19 April 2019 Pages: 1804 - 1805

    

31. “Can’t seem to keep my mind to it”: did Arthur Miller’s Salesman have dementia with Lewy bodies?

    • Conor Fearon
    • John-Paul Taylor
    • Sean O’Dowd

    Letter to the Editors 30 April 2019 Pages: 1806 - 1808

32. Update on narcolepsy

    • P. J. Reading

    Neurological Update 19 April 2019 Pages: 1809 - 1815

    

33. Anticholinergic drug usage and cognitive impairment: findings from three large European cohort studies

    • Mo Hu
    • Tom Hughes

    Journal club 13 June 2019 Pages: 1816 - 1818

34. James Crichton-Browne (1840–1938)

    • Marco Cambiaghi

    Pioneers in Neurology 04 October 2018 Pages: 1819 - 1820